Mediately Databáza Liekov icon

13.6 by Modra Jagoda


Apr 28, 2024

About Mediately Databáza Liekov

English

Information on medicines and Control of drug interactions for Slovakia

Introducing the Drug Interactions Check tool

The Mediately application has evolved! Now you can control drug interactions directly in the app and significantly influence the safety and effectiveness of patient treatment. You get a reliable and effective tool to help you identify potential drug interactions, show you the severity of interactions & how to resolve them. The Mediately app provides you with support and enables you to make informed decisions about your treatment.

Mediately Mediately Drug Database — Mobile assistant for faster diagnosis and treatment, now including a tool to check drug interactions. Also available on Android phone or tablet.

Thanks to the app, you can easily search the offline drug registry with more than 9,600 drugs and get instant access to interactive clinical tools and dosage calculators.

1. Get information about more than 9,600 medicines

For each drug, you can view detailed information including:

• Basic information about the drug (active substance, composition, pharmaceutical form, class, information on reimbursement of the drug from the public health insurance system);

• Important information from the SmPC document for the given drug (indications, dosage, contraindications, interactions, side effects, overdose, etc.);

• ATC classifications and parallel drugs;

• Packages and prices;

• Access to the complete SmPC document in PDF format (requires internet connection).

2. Search a wide range of interactive diagnostic tools

In addition to the complete drug database, the application contains a number of interactive clinical tools and dosage calculators useful in daily practice:

Discover the tools thousands of doctors use every day.

• CHA2DS2-VASc (Score for Atrial Fibrillation Stroke Risk, scoring system for CMP risk stratification in patients with atrial fibrillation);

• GCS (Glasgow Coma Scale, a scale assessing quantitative impairment of consciousness in adults);

• GFR (estimation of glomerular filtration according to the MDRD equation);

• HAS-BLED (a scoring system for determining the risk of major bleeding in patients with atrial fibrillation);

• MELD (Model for End-Stage Liver Disease, a scoring system used to assess the severity of chronic liver diseases);

• PERC score (Pulmonary Embolism Rule-out Criteria, scoring system of criteria for the exclusion of pulmonary embolism);

• Wells criteria for pulmonary embolism.

3. CME (Education)

Expand your knowledge and earn CME credits from the comfort of your home or office.

• Read an article or watch a video that interests you.

• The topic overview is constantly updated to provide you with useful insights from your field.

The application also contains the classification of diseases according to ICD-10 and the ATC classification system. We update it regularly so that you always have the latest information available.

Disclaimer: Parts of this app are intended for healthcare professionals as a decision support tool. It is not intended for use by patients and does not replace the advice of a doctor.

What's New in the Latest Version 13.6

Last updated on Apr 28, 2024

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request Mediately Databáza Liekov Update 13.6

Uploaded by

Apdul Samet Köroğlu

Requires Android

Android 7.0+

Available on

Get Mediately Databáza Liekov on Google Play

Show More

Mediately Databáza Liekov Screenshots

Comment Loading...
Languages
Languages
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.